Nektar Therapeutics Reports First Quarter 2024 Financial Results
Go back to Nektar Therapeutics Reports First Quarter 2024 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 74.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.53 | 52 Week High | $19.98 | |||
| Open | $74.53 | 52 Week Low | $10.52 | |||
| Day High | $74.53 | P/E | N/A | |||
| Day Low | $74.53 | EPS | $-1.45 | |||
| Volume | 15 | |||||
